Elite Health Systems Inc.
Elite Health Systems Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 2 | 2 | 0 | 1 | 1 | |||||
Assets Current | |||||||||||||||||
Assets Current | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | |||||
Income Taxes Receivable | - | - | - | - | - | 0 | - | - | - | 0 | - | - | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Notes And Loans Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | |||||
Other Assets | |||||||||||||||||
Property Plant And Equipm… | |||||||||||||||||
Financing Receivable Excluding Accrued Interest Af… | - | - | - | - | - | - | - | - | 1 | 1 | 0 | 0 | |||||
Notes Receivable Net | - | - | - | - | - | - | 1 | 1 | - | - | - | - | |||||
Assets Noncurrent | |||||||||||||||||
Long Term Accounts Notes And Loans Receivable Net … | - | - | - | - | 0 | 0 | - | - | - | 1 | - | - | |||||
Equity Method Investments | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | |||||||||||||||||
Other Assets Noncurrent | - | - | - | - | 0 | - | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Goodwill | 1 | 1 | - | - | - | 0 | - | - | - | - | - | - | |||||
Capitalized Computer Software Net | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | |||||
Property Plant And Equipm… | |||||||||||||||||
Property Plant And Equipment Net | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 5 | 7 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Income Taxes Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Contract With Customer Liability Current | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Liabilities | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | 4 | 5 | 5 | 4 | 4 | 4 | 4 | 2 | 0 | 1 | 1 | 1 | |||||
Common Stock Shares Subscriptions | - | - | 2 | 0 | 0 | 0 | - | - | - | 0 | - | - | |||||
Additional Paid In Capital Common Stock | 17 | 17 | 9 | 9 | 9 | 8 | 7 | 5 | 3 | 3 | 3 | 3 | |||||
Retained Earnings Accumulated Deficit | -14 | -12 | -6 | -5 | -5 | -4 | -3 | -3 | -3 | -2 | -2 | -2 | |||||
Minority Interest | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Liabilities And Stockholders Equity | 5 | 7 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 29 | 29 | 22 | 21 | 21 | 20 | 17 | 13 | 9 | 9 | 8 | 8 | |||||
Shares Outstanding | 29 | 29 | 22 | 21 | 21 | 20 | 17 | 13 | 9 | 9 | 8 | 8 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.87% | -5.61% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 32.94% | 35.29% | 64.71% | -12.32% | -11.59% | 2.17% | -8.67% | -16.00% | -8.00% | -20.00% | -12.80% | -19.20% |
| 2024 | -13.04% | 1.45% | -5.80% | 11.11% | 3.70% | 29.63% | -12.00% | -20.00% | -12.00% | 1.22% | 9.76% | 21.95% |
| 2023 | - | - | - | 16.67% | 75.00% | 116.67% | 8.00% | -16.00% | 0.00% | -11.25% | -13.75% | -28.75% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.40 | 3.35 | 15.83 | 18.93 | 73.14 | 45.20 | 34.31 | 2.30 | 0.82 | 0.87 | 3.03 | 4.55 | |||||
| Quick Ratio | 2.40 | 3.35 | 15.83 | 18.93 | 73.14 | 45.20 | 34.31 | 2.30 | 0.82 | 0.87 | 3.03 | 4.55 | |||||
| Working Capital | 1.91M | 3.14M | 4.00M | 3.00M | 3.68M | 4.16M | 3.10M | 1.27M | -396.00K | -80.00K | 388.00K | 629.00K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.34 | 0.25 | 0.06 | 0.05 | 0.02 | 0.03 | 0.04 | 0.52 | 6.81 | 1.05 | 0.30 | 0.23 | |||||
| Interest Coverage TTM | -336.43 | -295.31 | -120.48 | -103.06 | -134.15 | -163.00 | -771.00 | -435.33 | -370.33 | -382.50 | -1,036.00 | - | |||||
| Debt Ratio | 0.25 | 0.20 | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 | 0.34 | 0.87 | 0.51 | 0.23 | 0.19 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.50 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 18.54 | 60.95 | - | - | - | - | - | - | - | - | - | - | |||||
| Receivables Turnover TTM | 19.69 | 5.99 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | - | - | - | - | - | - | - | -0.08 | -0.09 | -0.02 | -0.05 | |||||
| Free Cash Flow Per Share TTM | -0.14 | -0.13 | -0.09 | -0.06 | -0.06 | -0.10 | -0.08 | -0.08 | -0.10 | -0.10 | -0.11 | -0.16 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -194.47% | -374.90% | - | - | - | - | - | - | - | - | - | - | |||||
| Net Profit Margin TTM | -358.13% | -762.11% | - | - | - | - | - | - | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 300.28% | 279.76% | 179.78% | 134.92% | 116.48% | 151.84% | 724.24% | 141.51% | 3.30% | -38.97% | -93.93% | -82.17% | |||||
| EPS Growth (1Y) | 195.87% | 158.23% | 119.00% | 47.96% | 22.19% | 52.06% | 282.50% | 41.35% | -31.92% | -48.45% | -94.01% | -82.40% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -4.14 | -3.65 | -8.71 | -11.33 | -7.98 | -5.99 | -8.75 | -9.62 | -9.51 | -5.12 | -12.56 | -1.85 | |||||
| P/B TTM | 8.85 | 5.36 | 5.28 | 6.50 | 4.09 | 2.94 | 2.60 | 4.45 | 28.59 | 6.48 | 2.48 | 0.87 | |||||
| P/S TTM | 14.84 | 27.83 | - | - | - | - | - | - | - | - | - | - | |||||
| Market Cap | 35.94M | 28.49M | 26.51M | 24.62M | 17.29M | 12.30M | 9.52M | 8.90M | 9.52M | 4.18M | 1.66M | 710.30K | |||||
| Enterprise Value | 33.34M | 24.74M | 22.54M | 21.50M | 13.59M | 8.27M | 6.35M | 6.71M | 7.77M | 3.71M | 1.10M | -65.70K | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -3.90M | -2.94M | -1.98M | -1.23M | -1.35M | -1.52M | -1.31M | -1.06M | -1.22M | -891.00K | -843.00K | -1.25M | |||||
| Net Debt | -2.60M | -3.76M | -3.97M | -3.12M | -3.70M | -4.03M | -3.17M | -2.20M | -1.75M | -466.00K | -559.00K | -776.00K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Elite Health Systems Inc. (EHSI) — SEC Financial Statements & Analysis
Elite Health Systems Inc. (EHSI) is a services-specialty outpatient facilities, nec company, incorporated in DE. Elite Health Systems Inc. trades on EHSI: OTC as: EHSI. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Elite Health Systems Inc. reported a Debt-to-Equity ratio of 0.34x, a Price-to-Sales (P/S) ratio of 14.84x (TTM), a Price-to-Book (P/B) ratio of 8.85 (TTM), at a market cap of $35.94M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.34x
- P/S TTM
- 14.84x
- P/B TTM
- 8.85
- Market Cap
- $35.94M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Elite Health Systems Inc. in?
Elite Health Systems Inc. (EHSI) operates in the Services-Specialty Outpatient Facilities, NEC industry.
What is EHSI's market cap?
Elite Health Systems Inc. (EHSI) has a market capitalization of $35.94M as of 2026-03-31.
What exchange does EHSI trade on?
Elite Health Systems Inc. (EHSI) trades on the EHSI: OTC.
Where is Elite Health Systems Inc. incorporated?
Elite Health Systems Inc. is incorporated in DE.